Order

Size
Price
Stock
Qty

PK-THPP

Axon 2403
CAS:  1332454-07-5
Purity:  99%
  • Soluble in DMSO
  • MF:  C29H32N4O2
  • MW:  468.59

Description

Potent TASK-3 (KCNK9) antagonist (IC50 value 303 nM and 35nM for TASK-1 and TASK-3, respectively) with >140 fold selectivity over a wider range of potassium channels. PK-THPP produced a significant increase in active wake with a concurrent decrease in both REM and delta sleep immediately following administration to wild-type (WT) mice, and stimulated breathing by increasing tidal volume and breathing rate in isoflurane-anesthetized rats. PK-THPP induced a respiratory alkalosis and increased oxygenation.

More Information

Parent CAS No. 1332454-07-5
Chemical Name 1-(1-(6-(Biphenylcarbonyl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)piperidin-4-yl)butan-1-one
SMILES C(C1CCN(C2N=CN=C3CCN(C(C4=CC=C(C5=CC=CC=C5)C=C4)=O)CC3=2)CC1)(=O)CCC
MFCD N.A.
InChi InChI=1S/C29H32N4O2/c1-2-6-27(34)23-13-16-32(17-14-23)28-25-19-33(18-15-26(25)30-20-31-28)29(35)24-11-9-22(10-12-24)21-7-4-3-5-8-21/h3-5,7-12,20,23H,2,6,13-19H2,1H3
InChiKey CJZGRIRZVHNUSM-UHFFFAOYSA-N
CID 53464059
Short Description TASK-3 antagonist

Related Products

AXON ID NAME FROM PRICE
1112 BMS 204352

From $143.00

1248 Zatebradine hydrochloride

From $132.00

1274 PNU 37883 hydrochloride

From $121.00

1294 Chromanol 293B

From $143.00

1305 XE 991 dihydrochloride

From $99.00

1308 (±)-BMS 204352

From $137.50

1309 (R)-(-)-BMS 204352

From $159.50

1313 1-EBIO

From $55.00

1322 DMP 543

From $99.00

1437 Flupirtine maleate

From $71.50

1525 Retigabine

From $99.00

1647 NN414

From $132.00

1657 S 9947

From $137.50

1735 Kv1.3 Channel blocker 42

From $121.00

1757 HMR 1098

From $104.50

2064 Glibenclamide potassium salt

From $55.00

2094 NS 6180

From $99.00

2103 Dofetilide

From $93.50

2243 AVE 0118 hydrochloride

From $132.00

2252 Retigabine dihydrochloride

From $99.00

2840 ML 365

From $148.50

2872 ML 335

From $121.00

3019 A2764 dihydrochloride

From $115.50

4122 C101248

From $132.00

Loading...